Open Access<p>Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β<sub>2</sub> Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study</p>
Author(s) -
Shih Lung Cheng,
Ming Lin Ho,
Yun Fa Lai,
Hao-Chien Wang,
Jeng Yuan Hsu,
Shih-Feng Liu,
Ming-Shyan Huang,
Cheng Hung Lee,
ChungSheng Lin,
LiangWen Hang,
Yu Chih Liu,
Kuang Yao Yang,
Jia Horng Wang
Publication year - 2020
Publication title -
drug design, development and therapy
Language(s) - English
Resource type - Journals
ISSN - 1177-8881
DOI - 10.2147/dddt.s266177
Subject(s) - formoterol , salmeterol , budesonide , fluticasone , medicine , fluticasone propionate , budesonide/formoterol , corticosteroid , formoterol fumarate , asthma , anesthesia